US Edition
Published • loading... • Updated
Remission Medical Closes Series A Led by Blue Heron Capital to Expand Virtual Rheumatology Partnerships Across U.S. Health Systems
Summary by Intelligence360 News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Remission Medical Closes Series A Led by Blue Heron Capital to Expand Virtual Rheumatology Partnerships Across U.S. Health Systems
Investment accelerates the company’s proven model of embedding specialty care directly inside health system operations, now active across major health system partners and backed by an AI-native workforce platform built to scale RICHMOND, Va., April 13, 2026 /PRNewswire/ — Remission Medical, Inc., a virtual rheumatology company that contracts directly with health systems to deliver embedded specialty care, today announced the close of a Series A …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
